He University of Notre DameThe Lucy Family Institute for Data and Society (Notre Dame, Ind.) is supported by a professional services firm Accent (Dublin, Ireland) to “harness the power of artificial intelligence and machine learning to understand and aim to solve the most intransigent healthcare challenges, specifically at the intersection of healthcare and social care” (January 4).
- Dr Nitesh Chawlafounding director of the Lucy Family Institute: “We are very grateful for Accenture’s support. We look forward to developing a framework for co-creation and co-innovation to advance solutions that address the challenges of health disparities, including but not limited to Responsible AI for Health, an annual index of health equity data. health and the addition of precision to the social determinants of health actions”.
MRI software provider perspective (Oxford, UK) has raised a new $36 million, bringing its total share from investors to around $120 million (Jan 5). The company plans to use the support to expand market share beyond the 77 million US adults who have had covered access to its MRI tool for assessing chronic liver disease, LiverMultiScan. Leading the new round of financing was Oppenheimer Holdings (New York, NY).
- President of Oppenheimer Holdings Robert Lowenthal: “Perspectum is a truly disruptive company with medical imaging software that can dramatically improve the standard of care for millions of patients, as well as provide a higher level of decision support for physicians. We anticipate that Perspectum will continue to lead the field of AI-enhanced imagery for years to come.”
Canon Medical Systems USA (Tustin, Calif.) partners with an image management team ScImage from Los Altos, California (January 9). Canon will use the collaboration to build its catheterization customer base while increasing its presence in the cardiac markets.
- Sai Raya, PhDScImage founder and CEO: “[I]In collaboration with Canon, we provide a powerful cloud-centric platform for the advancement of enterprise imaging. With a shared vision and perfectly complementary products, we can drive the future direction of cardiology and beyond.”
Promax (Oakland, California) sold eight of its AI-equipped MRI-guided prostate surgery systems in Q4 2022 (January 9). The company launched a year early and has now surpassed $15 million in sales.
- promax customer Dr Kalish KediaCleveland Urology Associates and Infinity Surgery Center: “This novel and disruptive technology will support our goals in clinical research to further improve urology care.”
RaySearch Laboratories (Stockholm, Sweden) won an order from The Ohio State University Comprehensive Cancer Center for RayStation, a proton therapy planning system that incorporates deep learning segmentation and other advanced technology features (January 9).
- Founder and CEO of RaySearch johan lof: “[W]We are proud that another leading proton clinic has selected the RayStation. We look forward to supporting OSUCC…in its clinical operation.”